masthead-news

News & Events

An Interview with Institute of Oncology Research, Dr. Francesco Bertoni, MD

"The HTG EdgeSeq technology represents a nice way to combine the possibility of working with FFPE specimens and next-generation approaches.  Moreover, the HTG EdgeSeq Oncology Biomarker Panel (OBP) can be applied on in vitro models and then the results can be validated on FFPE specimens from clinical studies using the same assay." Dr. Bertoni, MD

Read More

Posted on:
 

Two Tucson biotechs honored for fast-lane growth

Calimmune Inc. and HTG Molecular Diagnostics Inc. of Tucson will be joined by Phoenix-based VisionGate Inc. and recognized at the AZBio Awards on Oct. 1 at the Phoenix Convention Center. HTG Molecular has commercialized its HTG Edge instrument platform and a portfolio of gene-based tests using its proprietary, RNA-based technology.

Read More

Posted on:
 

Page last updated June 01, 2020